Subtropical and tropical regions register a high proportion of Arthropod-borne viral infections. According to the WHO, dengue is most common arbovirus disease, with nearly 40% of the world’s population at risk. Governments across the world are working closely with private companies and are actively involved in the development of rapid diagnostics for Arthropod-borne viral detection.
Owing to such developments, there has been increasing demand for ELISA-based tests, creating an absolute opportunity for growth of the Arthropod-borne viral infections testing market. FMI – a well-established name in the market research domain – forecasts that, the Arthropod-borne viral infections testing market will close in on a valuation of around US$ 2 Bn by the year 2029.
The coronavirus (COVID-19) pandemic is raging across continents, especially in North America and Europe. Governments as well the healthcare sector are racing to flatten the curve. Several diagnostic tests to treat COVID-19 patients have been availed currently, with more receiving emergency approvals. A majority of these testing methods are based on reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assays (ELISA). While the former is the current standard approach for COVID-19, the latter delivers faster clinical outcomes. The current alarming situation is accenting the need for Arthropod-borne viral infections testing more than ever.
Request a report sample to gain comprehensive insights at
https://www.futuremarketinsights.com/reports/sample/rep-gb-11572
| Arthropod-borne Viral Infections Testing Market Size (2022) | US$ 1.3 Bn |
| Predicted Net Worth (2029) | US$ 1.9 Bn |
| Global Market Growth Metrics (2022-2029) | 5.6% CAGR |
| Market Share of ELISA-based Tests | 52% |
Key Takeaways of Arthropod-borne Viral Infections Testing Market Study
- ELISA-based tests would contribute over half of the total Arthropod-borne viral infections testing market revenue.
- Owing to increasing acceptance in developing countries, ELISA-based tests are the preferred choice among customers.
- Public health laboratories will remain the key revenue generator in the Arthropod-borne viral infections testing market.
- The Middle East & Africa continues to engage market players, given the expanding patient pool suffering from viral infections. East Asia is also offering lucrative opportunities, owing increasing healthcare programs that financially aid the development of molecular testing kits such as ELISA and RT-PCR.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-11572
Strong Market Consolidation Activities Will Boost the Testing Market
At present, the Arthropod-borne viral infections testing market is characterized by a limited number of players, with a majority of them based in the U.S. Mergers and acquisitions are considered a differentiating strategy to penetrate into untapped markets and strengthen one’s market position. Manufacturers are mainly focused on developing new diagnostics based on microarray technology and mass spectrograph. Microarray technology majorly covers the detection of nucleic acid fragments of different Arthropod-borne pathogens that will help in identifying viral genotypes and serotypes. However, the technology is still under the developmental stage.
Want more insights?
Arthropod-borne viral infections testing market, a new study by Future Market Insights, opines on the application of Arthropod-borne viral infections testing from 2014 to 2021, and presents demand projections for 2022 to 2029, on the basis of test type (ELISA-based tests, RT-PCR-based tests, and immunochromatography rapid diagnosis) and end user (hospitals, public health laboratory, diagnostic centers, and others), across seven prominent regions.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-11572
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Point Of Care Blood Testing Devices Market – The global market of the point of care blood testing devices is driven by the increasing awareness among the population regarding to diabetes in adults and children. The key drivers of the market are increasing incidence of diabetes and different types of medical test.
Pancreatic Stone Protein Testing Market – The increasing cases of chronic diseases due to pancreatic stone formation expected to drive the market of pancreatic stone protein testing. The prevalence of diseases such as acute appendicitis, diabetes and optic atrophy drives the pancreatic stone protein testing market worldwide.
Preimplantation Genetic Testing Market – Preimplantation genetic testing or preimplantation genetic diagnosis is a technique in which the embryos prepared through in vitro fertilization are tested for defects before implantation.
Point-Of-Care Genetic Testing Market – Point-of-Care testing is defined as the clinical testing performed at or near the site where clinical care is being given to the patient. It can be performed by patients itself or any personnel.
Poultry Diagnostic Testing Market – “Poultry” is defined as livestock that are chickens, turkeys, ducks, waterfowl and other birds raised in the farm, excluding pigeons and doves. Diagnostic testing may incorporate ELISA Test, PCR Test other diagnostic tests.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/